Filter
275
Filtered Results: 275
Text search:
varicela
Featured
Recommendations
40
New Publications
86
Language
Document type
No document type
147
Guidelines
69
Studies & Reports
21
Manuals
15
Strategic & Response Plan
6
Fact sheets
6
Brochures
4
Training Material
3
Situation Updates
2
Resource Platforms
1
Infographics
1
Countries / Regions
India
15
Paraguay
11
Western and Central Europe
8
Venezuela
7
South Africa
7
Brazil
7
Latin America and the Carribbean
6
Colombia
5
Philippines
5
Global
5
Indonesia
5
Kenya
4
Ukraine
4
Rwanda
4
Cameroon
4
Nigeria
4
Malawi
4
Mozambique
4
Tanzania
4
Bangladesh
4
Namibia
4
Senegal
3
Haiti
3
Germany
3
Congo, Democratic Republic of
3
Ethiopia
3
Liberia
3
Ecuador
3
Nepal
2
El Salvador
2
Chile
2
Africa
2
Cambodia
2
West and Central Africa
2
Argentina
2
Uganda
2
Angola
2
Myanmar / Burma
2
Lesotho
1
Eastern Europe and Central Asia
1
Portugal
1
Bolivia
1
Eastern Europe
1
Russia
1
Libya
1
Botswana
1
Zambia
1
South Sudan
1
Eswatini/ Swaziland
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
134
Clinical Guidelines
51
Women & Child Health
19
Key Resources
13
Public Health
9
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
Rapid Response
29
COVID-19
22
HIV
15
TB
15
Refugee
12
Pharmacy
11
Caregiver
7
Zika
7
AMR
7
Ebola & Marburg
5
NTDs
5
Mental Health
4
Conflict
3
Natural Hazards
2
Planetary Health
2
NCDs
2
Specific Hazards
1
Disability
1
Polio
1
Typhoon
1
Vaksen kont Varisèl (Saranpyon):Sa Ou Dwe Konnen
Vaksen MMRV (Lawoujòl, Malmouton,
Ribeyòl, ak Varisèl): Sa Ou Dwe Konnen
i. A person who is a contact of a probable or confirmed mpox case in the 21 days before the onset of signs or symptoms, and who presents with any of the following: acute onset of fever (>38.5°C), headache, myalgia (muscle pain/body aches), back pain, profound weakness or fatigue.
OR
ii. A per...
Лучевые исследования в диагностике Covid-19 и алгоритмы действий
(ensuring COVID readiness of radiation diagnostics departments)
Accessed: 11.03.2019
3rd edition!
Vaccine Management in Indonesia
Accessed at March 2014
Guidelines for the Vaccination Plan against COVID-19 in children 5 to 11 years, 11 months, 29 days with COVID-19 Vaccine Coronovac / Sinovac
Skin and mucosal conditions are extremely common in all children and adults in particular in HIV-infected adults and children and are one of the commonest daily management problems faced by health care workers caring for patients with HIV infection
JOINT RESPONSE PLAN (JRP)
The Strategic Executive Group has developed a Joint Response Plan (JRP) for 2019 regarding the displaced people from Myanmar and who are affected specially by this influx The JRP has included different issues in terms of measuring people who are in need, of support interve...
